Here are three points:
1. The OssGro synthetic grafts complement Leader Biomedical’s existing eTiss line of human allografts used for spine, trauma and orthopedic indications.
2. The OssGro product range aims to further simulate the formation of new bone through the release of calcium and phosphate ions.
3. Leader Biomedical is a provider of biomaterials and medical implant solutions.
More articles on devices:
Bioventus gets rights to distribute GELSYN-3 in the US: 5 key notes
Nihon Kohden launches Neuromaster MEE-2000A — 5 highlights
OrthoGrid Systems releases HipGrid Drone: 4 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
